New-drug-of-Novartis-and-Lilly-was-successful-in-trials
New drug of Novartis and Lilly was successful in trials
Phase III REVEL study data say that the new drug of Novartis and Lilly is effective in metastatic non-small cell lung cancer cases. Ramucirumab showed very good results in clinical tests....
Tags: Ramucirumab, chemotherapy, cancer, Lilly, Novartis...
February 21, 2014
Gathering-cancer-cells-might-help
Gathering cancer cells might help
US researchers have found a new technology which they call "monorails". The technology is based on a technique whit the help of which they gather cells into a more operable format....
Tags: monorail, cancer, cell...
February 18, 2014
Fight-Against-seizures-with-the-power-of-Marijuana
Fight Against seizures with the power of Marijuana
A drug, derived form Marijuana is in clincal trial now. The research is very unique, since it is the first time that cannabis is tested as a cure for seizure and the tests are done by children's hospital. ...
Tags: marijuana, trial, epilepsy, children, seizure...
February 9, 2014
Killing-cancer-completely-in-bone-Marrow
Killing cancer completely in bone Marrow
Several drugs that use the body's own immune system to fight against tumor cells are proven to be effective during clinical trials. However, in some cases it has been made clear that the process is not complete, tumor comes back. However, a new invention of MIT might he...
Tags: MIT, drug, cancer, antibody, tumor, bone marrow...
February 6, 2014
Bladder-Cancer-study-offers-new-ways-in-cancer-therapy
Bladder Cancer study offers new ways in cancer therapy
The Cancer Genome Atlas was researched when scientist found new way for bladder-cancer therapy. The new possibilities include for example major bilogical pathways. ...
Tags: biology, cancer, bladder-cancer, biological pathway. Cancer Genome Atlas...
January 31, 2014
How-come-silk-and-diamonds-to-drug-discovery
How come silk and diamonds to drug discovery
There is a particle, which is only tens of nanometers across which is made of all "royal" materials. This stands of diamond covered in silk....
Tags: silk, diamond, nanoparticle...
January 29, 2014
Xarelto-as-rejected-by-FDA
Xarelto as rejected by FDA
Xarelto, the drug of Janssen was rejected by FDA. The edicine is used for treating secondary cardiovascular events - for instance heart attacks. Leaders of the research say, they remain committed to develop the drug....
Tags: Xarelto, coronary disease, drug, heart atack...
February 18, 2014
antioxidants-fastened-the-spread-of-cancer-cells-in-mice
antioxidants fastened the spread of cancer cells in mice
Two well-spread antioxidants seem to spees up the spread of cancer cells in mices. These antioxidants are ingredients of many well-known prvention drugs. ...
Tags: prevention, antioxidant, cacer, mice...
February 13, 2014
Electric-controll-of-drug-can-prevent-side-effects
Electric controll of drug can prevent side-effects
Several drugs have side effects because they are active in those parts of the body where they should not be. A group of scientists created a "smart" implant, which might solve this problem....
Tags: smart implant, scientists, side effects, drug development, electronic drug control...
February 9, 2014
A-promising-new-vaccine-for-rabies-is-found
A promising new vaccine for rabies is found
Over 60 000 peolpe are killed by rabies annually. The virus causes painful symptoms both for human and animals. However, a new invetnion of David Jans might be able to kill lyssaviruses, the cause of this deadly infection....
Tags: rabies, vaccine, human, lyssavirus...
February 6, 2014
A-new-SM-drug-is-being-developed-by-Tevan-and-Active-Biotech
A new SM drug is being developed by Tevan and Active Biotech
Despite of the negative opinion of Committee for Medicinal Products for Human Use, Teva and Active Biotech are still commited to develop Nerventra. It was told that the risk-rate of this medicine is not satisfying....
Tags: Nerventra, Teva, Active Biotech, MS...
January 29, 2014
Novartis-looks-forward-to-have-its-new-drug-accepted-in-the-EU
Novartis looks forward to have its new drug accepted in the EU
Novartis has announced that it has submitted the revised service pack of Serelaxin to Committee for Medicinal Products for Human Use (CHMP). This drug is used in case of chronic heart failure. ...
Tags: chronic heart failure, Committee for Medicinal Products for Human Use, Serelaxin...
January 29, 2014
MOST VIEWED

HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013